Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
about
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature.Evaluation of prognostic factors for secondary cytoreductive surgery in Chinese patients with recurrent epithelial ovarian carcinoma.Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer.Latest research and treatment of advanced-stage epithelial ovarian cancerSecondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancerSurvival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histologyCytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience.Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer.Laparoscopic-based score assessment combined with a multiple disciplinary team in management of recurrent ovarian cancer: A single-center prospective study for personalized surgical therapy.Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelial ovarian, tubal, or peritoneal carcinoma: A propensity score-matched analysis of 112 consecutive patients.Secondary cytoreduction versus chemotherapy alone in the treatment of patients with recurrent ovarian cancer: is a randomized trial worthwhile?Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer.Comparison of (18)F-FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study.Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer.
P2860
Q27692699-5EBA02F1-B14D-4A2A-931D-C56D29E5126DQ34491120-8C875207-18D5-4F18-809C-CB39A1D7B5BBQ34557778-949B53A7-E613-47BE-B090-D6150E2BEEA9Q35173729-092ED048-BDD3-4B04-A3D0-DD914726D568Q35867496-37555044-9222-432A-8398-F35C9A6F210FQ35954103-9E76729A-C4A8-44CE-89F8-E587164F0D86Q36433053-02CAEC03-B392-49DB-BA83-C5BC169459E8Q36751103-11D34037-3027-4A8D-8DCF-4DDE75696C57Q37206348-531991D4-5057-441B-9178-66081CC69462Q37356602-383FF4FB-4AD8-4379-9A09-F3627F19DAB8Q37486156-40316230-762E-462F-9615-0F237B97ED05Q37683243-AE58D3FF-6C25-406E-9768-F80997AED199Q38155428-AF494BC6-FB03-4A98-9D19-BED35453FEA7Q38600645-D28EB8D1-76B1-4982-BB30-598C1C0D1287Q38719149-A01C869C-A76C-4995-9CBC-28C7B4F15C9AQ40251231-55742B5F-E60C-4089-8A3A-A9129C549344Q42108950-4A1B71C6-105C-4C27-B8C0-22CE4F3093ABQ42170049-9853321F-C321-474A-BC2A-CC30E86541FBQ42360773-2DE08A02-CD8F-461F-8A30-96AADACDA083Q43559938-E8CC97B4-04A3-4811-8B3F-DA1857BDF8C5Q43695138-91073CF0-B792-4725-9C85-6A678B604ED9Q49822895-21D8C4D2-15C7-4615-894F-039033E18BB4Q51050471-E385E3CE-F00E-413A-9140-325C10511A75
P2860
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predictors of survival in pati ...... national collaborative cohort.
@ast
Predictors of survival in pati ...... national collaborative cohort.
@en
type
label
Predictors of survival in pati ...... national collaborative cohort.
@ast
Predictors of survival in pati ...... national collaborative cohort.
@en
prefLabel
Predictors of survival in pati ...... national collaborative cohort.
@ast
Predictors of survival in pati ...... national collaborative cohort.
@en
P2093
P2860
P356
P1476
Predictors of survival in pati ...... national collaborative cohort.
@en
P2093
C A Rabbitt
C Fotopoulou
E I Braicu
H Oksefjell
J Pfisterer
P2860
P2888
P304
P356
10.1038/BJC.2011.328
P407
P577
2011-08-30T00:00:00Z